Deccan Chronicle

Pharma, med tech not sure of govt targets

- SANGEETHA G

Net new enrolments with the EPFO rose to 6.55 lakh in June from 1.72 lakh in May, according to its latest payroll data. Its provisiona­l payroll data last month had shown that net new enrolments stood at 3.18 lakh in May but the figure has now been revised to 1,72,174. Net new enrolments with the EPFO hover around 7 lakh every month. Latest data shows net new enrolments in April were just 20,164 against 1 lakh stated in July.

The government expects bulk drug and medical device parks to attract cumulative investment of about Rs 77,900 crore and generation of about

2,55,000 employment. The industry, however, finds it very ambitious.

The government had announced schemes for developmen­t of three bulk drug parks and four medical device parks. Apart from increasing central assistance for developmen­t of common infrastruc­ture facilities in the parks, the government will also extend production-linked incentive (PLI) to manufactur­ers of bulk drugs and medical devices in these parks.

“Government will provide an incentive at the rate of 5 per cent on incrementa­l sales for a period of five years from

2021-22 to 2025-26 with a total outlay of Rs 3.420 crore, minister of chemicals and fertiliser­s D. V. Sadananda Gowda said at an event.

According to him, bulk drug and medical device parks are expected to attract cumulative investment of about Rs 77,900 crore and can generate about 2,55,000 employment. For the medical device sector alone, investment could be to the tune of Rs 40,000 crore with generation of 1,40,000 new employment opportunit­ies.

However, the industry is not quite convinced about the government estimate. “This is the assumption of the government. We will have to wait and watch. They assume that companies will leave China and come here. But that might not happen immediatel­y. Even among domestic companies we have not seen a huge interest to invest thousands of crores,” said G.S.K. Velu, chairman and MD of Trivitron Healthcare.

According to pharma veteran S. V. Veeramani, some states like Haryana, Gujarat and Telangana have evinced interest in setting up the parks. “Pharma companies might be interested in establishi­ng API manufactur­ing plants. But whether, they will bring in around Rs 38,000 crore of investment has to be seen,” he said.

New Delhi, Aug. 20: Gmail service, which suffered a global outage for hours on Thursday, has now been restored, according to Google.

Some users faced issues with Gmail like being unable to log in, add attachment­s and receive messages since morning.

On Thursday morning, GSuite status dashboard—which provides performanc­e informatio­n on various Google services—said the company was investigat­ing reports of an issue with Gmail.

When contacted, a Google spokespers­on confirmed that the problem has now been resolved.

In its latest update, Google said: "...We apologise for the inconvenie­nce and thank you for your patience and continued support. System reliabilit­y is a top priority at Google. We are making continuous improvemen­ts to make our systems better". The firm provided multiple updates, stating it is investigat­ing the issue and that there was a disruption in sending emails, Meet recording and creating files in Drive, among others. — PTI

Newspapers in English

Newspapers from India